WallStreetZen

NASDAQ: IRTC
iRhythm Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IRTC

Based on 6 analysts offering 12 month price targets for iRhythm Technologies Inc.
Min Forecast
$78.00+33.54%
Avg Forecast
$123.33+111.15%
Max Forecast
$288.00+393.07%

Should I buy or sell IRTC stock?

Based on 8 analysts offering ratings for iRhythm Technologies Inc.
Buy
Strong Buy
2 analysts 25%
Buy
0 analysts 0%
Hold
6 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

IRTC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Morgan Stanley
Bottom 50%
50
HoldMaintains$85.00+45.52%2021-06-03
Citigroup
Top 5%
96
HoldDowngrades$78.00+33.54%2021-06-02
Morgan Stanley
Top 6%
95
HoldDowngrades$94.00+60.93%2021-04-14
Truist Securities
Top 11%
90
Strong BuyMaintains$115.00+96.88%2021-04-13
BTIG
Top 10%
91
HoldDowngradesN/AN/A2021-04-13
Baird
Top 17%
84
HoldMaintains$80.00+36.96%2021-04-12
Colliers Securities
Bottom 12%
12
HoldDowngradesN/AN/A2021-02-26
Anonymous
Morgan Stanley
Strong BuyMaintains$288.00+393.07%2021-01-25

1 of 1

Forecast return on equity

Is IRTC forecast to generate an efficient return?
Company
-26.19%
Industry
18.2%
Market
1,975.19%
IRTC's Return on Equity is forecast to be low in 3 years (-26.19%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is IRTC forecast to generate an efficient return on assets?
Company
-16.54%
Industry
11.22%
Market
951.37%
IRTC is forecast to generate lower Return on Assets (-16.54%) than the US Medical Instruments & Supplies industry average (11.22%)
Forecast

IRTC earnings per share forecast

What is IRTC's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$3.66+79.41%
Avg 2 year Forecast
-$3.50+71.57%
Avg 3 year Forecast
-$2.73+33.82%

IRTC revenue forecast

What is IRTC's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$323.3M+5.55%
Avg 2 year Forecast
$343.4M+12.11%
Avg 3 year Forecast
$376.3M+22.83%
IRTC's revenue is forecast to grow at a rate of 6.43% per year, which is not exceptional
Forecast

IRTC revenue growth forecast

How is IRTC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
6.43%
Industry
7.44%
Market
14.64%
IRTC's revenues are forecast to grow slower (6.43% per year) than the US Medical Instruments & Supplies industry average (7.44%)
Forecast
IRTC's revenues are forecast to grow slower (6.43% per year) than the US market average (14.64%)
Forecast

iRhythm Technologies Stock Forecast FAQ

Is iRhythm Technologies Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: IRTC) stock is to Buy IRTC stock.

Out of 8 analysts, 2 (25%) are recommending IRTC as a Strong Buy, 0 (0%) are recommending IRTC as a Buy, 6 (75%) are recommending IRTC as a Hold, 0 (0%) are recommending IRTC as a Sell, and 0 (0%) are recommending IRTC as a Strong Sell.

What is IRTC's earnings growth forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 30.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.98%.

iRhythm Technologies's earnings in 2021 is -$59,467,000.On average, 5 Wall Street analysts forecast IRTC's earnings for 2021 to be $-107,616,298, with the lowest IRTC earnings forecast at $-112,026,802, and the highest IRTC earnings forecast at $-103,793,861. On average, 6 Wall Street analysts forecast IRTC's earnings for 2022 to be $-102,911,760, with the lowest IRTC earnings forecast at $-133,785,288, and the highest IRTC earnings forecast at $-67,627,728.

In 2023, IRTC is forecast to generate $-80,271,173 in earnings, with the lowest earnings forecast at $-89,092,181 and the highest earnings forecast at $-71,156,131.

What is IRTC's revenue growth forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's forecast annual revenue growth rate of 6.43% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.64%.

iRhythm Technologies's revenue in 2021 is $306,342,000.On average, 5 Wall Street analysts forecast IRTC's revenue for 2021 to be $9,507,194,212, with the lowest IRTC revenue forecast at $9,479,643,264, and the highest IRTC revenue forecast at $9,530,511,077. On average, 6 Wall Street analysts forecast IRTC's revenue for 2022 to be $10,098,260,555, with the lowest IRTC revenue forecast at $7,997,713,920, and the highest IRTC revenue forecast at $10,936,697,365.

In 2023, IRTC is forecast to generate $11,063,984,511 in revenue, with the lowest revenue forecast at $9,585,495,360 and the highest revenue forecast at $12,332,357,251.

What is IRTC's forecast return on assets (ROA) for 2021-2023?

(NASDAQ: IRTC) forecast ROA is -16.54%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.22%.

What is IRTC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IRTC price target, the average IRTC price target is $123.33, with the highest IRTC stock price forecast at $288.00 and the lowest IRTC stock price forecast at $78.00.

On average, Wall Street analysts predict that iRhythm Technologies's share price could stay at $123.33 by Jun 3, 2022. The average iRhythm Technologies stock price prediction forecasts a potential downside of N/A from the current IRTC share price of $58.41.

What is IRTC's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: IRTC) iRhythm Technologies's current Earnings Per Share (EPS) is -$2.04. On average, analysts forecast that IRTC's EPS will be $-3.66 for 2021, with the lowest EPS forecast at $-3.81, and the highest EPS forecast at $-3.53. On average, analysts forecast that IRTC's EPS will be $-3.50 for 2022, with the lowest EPS forecast at $-4.55, and the highest EPS forecast at $-2.30. In 2023, IRTC's EPS is forecast to hit $-2.73 (min: $-3.03, max: $-2.42).

What is IRTC's forecast return on equity (ROE) for 2021-2023?

(NASDAQ: IRTC) forecast ROE is -26.19%, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.